Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06543290 · ClinicalTrials.gov registry record · Phase 1

Azithromycin Before Induction

A Phase 1 study of Infections, sponsored by Arrowhead Regional Medical Center.

Recruiting
Registry status
Phase 1
Development phase
400
Enrollment target
1
Study location

NCT06543290 is a Phase 1 study of Infections that is actively recruiting participants, run by Arrowhead Regional Medical Center. The registered enrollment target is 400 participants, below the 3,392-participant average among 26 other Infections trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06543290, a Phase 1 study of Infections, is actively recruiting participants, sponsored by Arrowhead Regional Medical Center.

RECRUITING
Registry status
Phase 1
Development phase
400 participants
Enrollment target
1
Study location

Study Summary

This is a double blinded randomized control trial involving administration of 2 grams prophylactic azithromycin in third trimester patients undergoing induction of labor at our institution to demonstrate reduction in maternal and neonatal infection.

Conditions Studied

Interventions

  • DRUG Placebo
  • DRUG Azithromycin Pill

Study Locations (1)

California

  • Arrowhead Regional Medical Center - Colton

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2023-08-07
Est. Completion 2026-08-07
Phase Phase 1

Sponsor

Arrowhead Regional Medical Center

13 total trials

What the Registry Record Tells You About NCT06543290

The ClinicalTrials.gov registry entry for NCT06543290 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,392-participant average among 26 other Infections trials with a reported enrollment target (88% lower). The listed sponsor is Arrowhead Regional Medical Center, which has 13 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Infections appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT06543290 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06543290 about?

NCT06543290 is a clinical study titled "Azithromycin Before Induction". This is a double blinded randomized control trial involving administration of 2 grams prophylactic azithromycin in third trimester patients undergoing induction of labor at our institution to demonstrate reduction in maternal and neonatal infection.

What is the current status of trial NCT06543290?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 400 participants. The study started on 2023-08-07. Estimated completion is 2026-08-07.

What conditions does trial NCT06543290 study?

This clinical trial studies the following conditions: Infections.

What interventions are being tested in trial NCT06543290?

The interventions under investigation include: Placebo (DRUG), Azithromycin Pill (DRUG).

Who is sponsoring clinical trial NCT06543290?

This trial is sponsored by Arrowhead Regional Medical Center, which has 13 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06543290 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.